Paula Sanchis

Mrs. Paula Sanchis

Universitat Autònoma de Barcelona
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
AEAnna Escrig
Anna Escrig
CCCarla Canal
Carla Canal
PSPaula Sanchis
Paula Sanchis
OGOlaya Fernandez Gayol
Olaya Fernandez Gayol
AMAlejandro Montilla
Alejandro Montilla
JHJuan Hidalgo
Juan Hidalgo

4 December 2019 in Glia
Verified
Journal Article
Closed access
PDF file
PSPaula Sanchis
Paula Sanchis
OFOlaya Fernández‐Gayol
Olaya Fernández‐Gayol
JVJoel Vizueta
Joel Vizueta
GOGemma Comes orpinell
Gemma Comes orpinell
CCCarla Canal
Carla Canal
JHJuan Hidalgo
Juan Hidalgo

31 January 2020 in Cells
Verified
Journal Article
Open access
PDF file
PSPaula Sanchis
Paula Sanchis
OGOlaya Fernandez Gayol
Olaya Fernandez Gayol
GOGemma Comes orpinell
Gemma Comes orpinell
AEAnna Escrig
Anna Escrig
MCMerce Giralt Carbonell
Merce Giralt Carbonell
JHJuan Hidalgo
Juan Hidalgo
Background: Interleukin-6 (IL-6) is a pleiotropic and multifunctional cytokine that plays a critical role in induction of experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). Although EAE has always been considered a peripherally elicited disease, Il6 expression exclusively within central nervous system is sufficient to induce EAE development. Neurons, astrocytes, and microglia can secrete and respond to IL-6. Methods: To dissect the relevance of each cell source for establishing EAE, we generated and immunized conditional Il6 knockout mice for each of these cell types with myelin oligodendrocyte glycoprotein 35-55 (MOG35-55) peptide dissolved in complete Freund’s adjuvant (CFA) and supplemented with Mycobacterium tuberculosis. Results and conclusions: The combined results reveal a minor role for Il6 expression in both astrocytes and microglia for symptomatology and neuropathology of EAE, whereas neuronal Il6 expression was not relevant for the variables analyzed.

2 July 2020 in Cells
Verified
Journal Article
Open access
PDF file
AEAnna Escrig
Anna Escrig
AMAmalia Molinero
Amalia Molinero
BMBrenda Méndez
Brenda Méndez
MCMerce Giralt Carbonell
Merce Giralt Carbonell
GOGemma Comes orpinell
Gemma Comes orpinell
JHJuan Hidalgo
Juan Hidalgo
Alzheimer’s disease (AD) is a neurodegenerative disorder that causes the most prevalent dementia in the elderly people. Obesity and insulin resistance, which may cause major health problems per se, are risk factors for AD, and cytokines such as interleukin-6 (IL-6) have a role in these conditions. IL-6 can signal either through a membrane receptor or by trans-signaling, which can be inhibited by the soluble form of the co-receptor gp130 (sgp130). We have addressed the possibility that blocking IL-6 trans-signaling in the brain could have an effect in the triple transgenic 3xTg-AD mouse model of AD and/or in obesity progression, by crossing 3xTg-AD mice with GFAP-sgp130Fc mice. To serve as control groups, GFAP-sgp130Fc mice were also crossed with C57BL/6JOlaHsd mice. Seventeen-month-old mice were fed a control diet (18% kcal from fat) and a high-fat diet (HFD; 58.4% kcal from fat). In our experimental conditions, the 3xTg-AD model showed a mild amyloid phenotype, which nevertheless altered the control of body weight and related endocrine and metabolic factors, suggestive of a hypermetabolic state. The inhibition of IL-6 trans-signaling modulated some of these traits in both 3xTg-AD and control mice, particularly during HFD, and in a sex-dependent manner. These experiments provide evidence of IL-6 trans-signaling playing a role in the CNS of a mouse model of AD.

15 October 2020 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
PSPaula Sanchis
Paula Sanchis
OGOlaya Fernandez Gayol
Olaya Fernandez Gayol
GCGemma Comes
Gemma Comes
KAKevin Aguilar
Kevin Aguilar
AEAnna Escrig
Anna Escrig
JHJuan Hidalgo
Juan Hidalgo
Background: Interleukin-6 (IL-6) is a pleiotropic cytokine that controls numerous physiological processes both in basal and neuroinflammatory conditions, including the inflammatory response to experimental autoimmune encephalomyelitis (EAE). IL-6 is produced by multiple peripheral and central cells, and until now, the putative roles of IL-6 from different cell types have been evaluated through conditional cell-specific IL-6 knockout mice. Nevertheless, these mice probably undergo compensatory responses of IL-6 from other cells, which makes it difficult to assess the role of each source of IL-6.Methods: To give some insight into this problem, we have produced a novel mouse model: a conditional reversible IL-6 KO mouse (IL6-DIO-KO). By using double-inverted, open-reading-frame (DIO) technology, we created a mouse line with the loss ofIl6expression in all cells that can be restored by the action of Cre recombinase. Since microglia are one of the most important sources and targets of IL-6 into the central nervous system, we have recovered microglialIl6expression in IL6-DIO-KO mice through breeding toCx3cr1-CreER mice and subsequent injection of tamoxifen (TAM) when mice were 10–16 weeks old. Then, they were immunized with myelin oligodendrocyte glycoprotein 35-55 peptide (MOG35-55) 7 weeks after TAM treatment to induce EAE. Clinical symptoms and demyelination, CD3 infiltration, and gliosis in the spinal cord were evaluated.Results: IL6-DIO-KO mice were resistant to EAE, validating the new model. Restoration of microglialIl6was sufficient to develop a mild version of EAE-related clinical symptoms and neuropathology.Conclusions: IL6-DIO-KO mouse is an excellent model to understand in detail the role of specific cellular sources of IL-6 within a recovery-of-function paradigm in EAE.

13 January 2019 in Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
OFOlaya Fernández-Gayol
Olaya Fernández-Gayol
PSPaula Sanchis
Paula Sanchis
KAKevin Aguilar
Kevin Aguilar
ANAlicia Navarro-Sempere
Alicia Navarro-Sempere
GOGemma Comes orpinell
Gemma Comes orpinell
JHJuan Hidalgo
Juan Hidalgo
Background/Aims: Interleukin-6 (IL-6) is a major cytokine controlling body weight and metabolism, at least in part through actions in the central nervous system (CNS) from local sources. Methods: We herewith report results obtained in conditional IL-6 KO mice for brain cells (Il6ΔGfap and Il6ΔSyn). Results: The reporter RiboTag mouse line demonstrated specific astrocytic expression of GFAP-dependent Cre in the hypothalamus but not in other brain areas, whereas that of synapsin 1-dependent Cre was specific for neurons. Feeding a high-fat diet (HFD) or a control diet showed that Il6ΔGfap and Il6ΔSyn mice were more prone and resistant, respectively, to HFD-induced obesity. Energy intake was not altered in HFD experiments, but it was reduced in Il6ΔSyn male mice following a 24-h fast. HFD increased circulating insulin, leptin, and cholesterol levels, decreased triglycerides, and caused impaired responses to the insulin and glucose tolerance tests. In Il6ΔGfap mice, the only significant difference observed was an increase in insulin levels of females, whereas in Il6ΔSyn mice the effects of HFD were decreased. Hypothalamic Agrp expression was significantly decreased by HFD, further decreased in Il6ΔGfap, and increased in Il6ΔSyn female mice. Hypothalamic Il-6 mRNA levels were not decreased in Il6ΔSyn mice and even increased in Il6ΔGfapmale mice. Microarray analysis of hypothalamic RNA showed that female Il6ΔGfap mice had increased interferon-related pathways and affected processes in behavior, modulation of chemical synaptic transmission, learning, and memory. Conclusion: The present results demonstrate that brain production of IL-6 regulates body weight in the context of caloric excess and that the cellular source is critical.